Finafloxacin

非那沙星

Report date: 2026/04/28 20:00:22
NMEQIDP

Base Information

Drug NameFinafloxacin
Drug Alias NameGastroquinoloneGastrochinolonFinafloxacinumFinafloxacinoFinafloxacine +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsDyspepsiaPyelonephritisOtitis Media with Effusion +[8] 
Global Approved IndicationsOtitis Externa
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/12/17
Country/TerritoryUnited StatesSingaporeGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesFonseca Biosciences LLC
Inactive CompaniesMerlion Pharmaceuticals GmbhAlcon
Active IndicationsOtitis Externa
Inactive IndicationsDyspepsiaPyelonephritisOtitis Media with Effusion +[7] 

Other Information

ATC CodeB05CAS01AS02AA +[4] 
Related LinksWikipediaDrugBankKEGG